Specialty Endocrinology
-
Featured
Preventing Heart Disease After HIV Infection
Research at Massachusetts General Hospital has led to several landmark studies, including the REPRIEVE trial, aimed at understanding and preventing HIV-related heart disease.
-
Featured
Diet High in Plant Foods Linked to Lower Risk, Severity of COVID-19
Jordi Merino, PhD, Andrew T. Chan, MD, MPH, and colleagues found that among 592,571 adults in the U.S. and U.K., a diet high in healthy plant foods was associated with lower risk and severity of COVID-19, even after accounting for health status, health behaviors, socioeconomic status and virus transmission measures.
-
Continuous Glucose Monitoring Shows Promise for Diagnosis of Cystic Fibrosis–Related Diabetes
Melissa S. Putman, MD, and colleagues found measures of hyperglycemia and glycemic variability provided by continuous glucose monitors were superior to hemoglobin A1c in distinguishing between patients with cystic fibrosis (CF) who did and did not have CF-related diabetes.
-
Different Brands of Continuous Glucose Monitors Yield Similar Measurements in Healthy Individuals
Jordi Merino, PhD, of the Diabetes Unit, and colleagues found good agreement between continuous glucose monitors (CGMs) of different brands when measuring glycemic responses to different foods and meals. Their findings suggest CGMs could someday be used to provide precision nutrition advice to healthy individuals.
-
Early Increase in Physical Activity Predicts Longer-term Improvement by Patients With Type 2 Diabetes
Emily H. Feig, PhD, and Jeff C. Huffman, MD, of the Department of Psychiatry, and colleagues suggest that when patients with type 2 diabetes and low self-reported physical activity take part in a behavioral intervention, their early progress is a good predictor of their longer-term improvement in activity.
-
Newly Identified Genetic Variant Has Substantial Effect on Risk of Type 2 Diabetes
Most genome-wide association studies (GWAS) are likely to miss variants with recessive effects. In a large recessive-model GWAS, Massachusetts General Hospital researchers identified a novel locus associated with 2.56 greater risk of type 2 diabetes in homozygous carriers that also had substantial effects on lipids.
Endocrinology Contributors
-
Camille E. Powe, MD
Endocrinologist, Massachusetts General Hospital, Co-Director, Diabetes in Pregnancy Program
Recent Article
Carbohydrate Intake Before Oral Glucose Tolerance Test May Prevent Accurate Diagnosis of Gestational Diabetes
-
Elizabeth A. Lawson, MD
Clinician, Neuroendocrine Clinical Center, Massachusetts General Hospital, Faculty, Neuroendocrine Unit, Massachusetts General Hospital, Assistant Professor of Medicine, Harvard Medical School
Recent Article
Restrictive Eating Disorders May Disrupt White Matter Development -
Joel S. Finkelstein, MD
Endocrinologist, Massachusetts General Hospital, Associate Director, Bone Density Center, Endocrine Unit, Massachusetts General Hospital
Recent Article
Ivacaftor Improves Skeletal Outcomes in Patients with Cystic Fibrosis -
Jose C. Florez, MD, PhD
Chief, Diabetes Unit, Endocrine Division, John T. Potts Jr., MD Endowed Chair in Medicine, Massachusetts General Hospital, Professor of Medicine, Harvard Medical School
Recent Article
Newly Identified Genetic Variant Has Substantial Effect on Risk of Type 2 Diabetes
-
Melissa S. Putman, MD
Endocrinologist, Massachusetts General Hospital, Assistant Professor of Pediatrics, Harvard Medical School
Recent Article
Continuous Glucose Monitoring Shows Promise for Diagnosis of Cystic Fibrosis–Related Diabetes -
Steven Kyle Grinspoon, MD
Chief, Metabolism Unit, Massachusetts General Hospital, Director, Nutrition Obesity Research Center, Harvard
Recent Article
Preventing Heart Disease After HIV Infection
Endocrinology Division
The Endocrinology Division at Massachusetts General Hospital offers a comprehensive integrated program of clinical services for both primary and tertiary care of adults with endocrine disorders.